These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7776085)

  • 1. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype.
    Husson RN; Lan Y; Kojima E; Venzon D; Mitsuya H; McIntosh K
    J Pediatr; 1995 Jun; 126(6):865-71. PubMed ID: 7776085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
    Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
    J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission.
    Lathey JL; Tsou J; Brinker K; Hsia K; Meyer WA; Spector SA
    J Infect Dis; 1999 Aug; 180(2):344-50. PubMed ID: 10395848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus.
    Aleixo LF; Goodenow MM; Sleasman JW
    J Pediatr; 1997 Jun; 130(6):906-14. PubMed ID: 9202612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group.
    Rich KC; Fowler MG; Mofenson LM; Abboud R; Pitt J; Diaz C; Hanson IC; Cooper E; Mendez H
    Pediatrics; 2000 Jan; 105(1):e8. PubMed ID: 10617745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children.
    Balotta C; Colombo MC; Colucci G; Viganò A; Riva C; Papagno L; Violin M; Crupi L; Bricalli D; Salvaggio A; Moroni M; Principi N; Galli M
    Pediatr Infect Dis J; 1997 Feb; 16(2):205-11. PubMed ID: 9041602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group.
    Hengel RL; Kennedy MS; Steketee RW; Thea DM; Abrams EJ; Lambert G; McDougal JS
    AIDS Res Hum Retroviruses; 1998 Apr; 14(6):475-81. PubMed ID: 9566549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1.
    Burns DN; Landesman S; Wright DJ; Waters D; Mitchell RM; Rubinstein A; Willoughby A; Goedert JJ
    J Infect Dis; 1997 May; 175(5):1206-10. PubMed ID: 9129087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virologic characterization of primary human immunodeficiency virus type 1 infection in a health care worker following needlestick injury.
    Pratt RD; Shapiro JF; McKinney N; Kwok S; Spector SA
    J Infect Dis; 1995 Sep; 172(3):851-4. PubMed ID: 7658081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1.
    Bal AK; Miller G; Viscarello R; Andiman WA
    Pediatr Infect Dis J; 1996 Apr; 15(4):315-20. PubMed ID: 8866800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Read JS; Rich KC; Korelitz JJ; Mofenson LM; Harris R; Moye JH; Meyer WA; Pahwa SG; Bethel JW; Nugent RP
    Pediatr Infect Dis J; 2000 Jun; 19(6):544-51. PubMed ID: 10877171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of mother-to-infant HIV transmission in tribal women from India.
    Kumar RM; Uduman SA; Khurranna AK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):238-42. PubMed ID: 7788422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Shaffer N; Roongpisuthipong A; Siriwasin W; Chotpitayasunondh T; Chearskul S; Young NL; Parekh B; Mock PA; Bhadrakom C; Chinayon P; Kalish ML; Phillips SK; Granade TC; Subbarao S; Weniger BG; Mastro TD
    J Infect Dis; 1999 Mar; 179(3):590-9. PubMed ID: 9952365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies.
    Khouri YF; McIntosh K; Cavacini L; Posner M; Pagano M; Tuomala R; Marasco WA
    J Clin Invest; 1995 Feb; 95(2):732-7. PubMed ID: 7860754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission.
    Fang G; Burger H; Grimson R; Tropper P; Nachman S; Mayers D; Weislow O; Moore R; Reyelt C; Hutcheon N; Baker D; Weiser B
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12100-4. PubMed ID: 8618852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. New York City Perinatal HIV Transmission Collaborative Study Group.
    Lambert G; Thea DM; Pliner V; Steketee RW; Abrams EJ; Matheson P; Thomas PA; Greenberg B; Brown TM; Bamji M; Kalish ML
    J Pediatr; 1997 Jun; 130(6):890-7. PubMed ID: 9202610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery.
    Coll O; Hernandez M; Boucher CA; Fortuny C; de Tejada BM; Canet Y; Caragol I; Tijnagel J; Bertran JM; Espanol T
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):26-30. PubMed ID: 8989207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand.
    Chuachoowong R; Shaffer N; VanCott TC; Chaisilwattana P; Siriwasin W; Waranawat N; Vanprapar N; Young NL; Mastro TD; Lambert JS; Robb ML
    J Infect Dis; 2000 Jun; 181(6):1957-63. PubMed ID: 10837175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.